6 research outputs found

    Modifier genes analysis by PCR-RFLP adapted from previously published techniques [21]–[24].

    No full text
    <p>Modifier genes analysis by PCR-RFLP adapted from previously published techniques <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0090945#pone.0090945-Sandford1" target="_blank">[21]</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0090945#pone.0090945-Chen1" target="_blank">[24]</a>.</p

    PCR-RFLP for the modifier genes analysis.

    No full text
    <p>1A: the 134 bp PCR product from exon 1 of the MBL1 gene was digested with <i>Mwo</i> I, <i>Ban</i> I and <i>Mbo</i> II for detection of polymorphisms in the 52, 54 and 57 codons. 1B: the 816 bp PCR product from promoter region of the IL-8 gene was digested with <i>Mfe</i> I for detection of the −251 polymorphism. 1C: the 142 bp PCR product from promoter region of the TNFα gene was digested with <i>Nco</i> I for detection of the −308 polymorphism (TNF2); the 98 bp PCR product from the SERPINA1 gene was digested with <i>Taq</i> I<sup>α</sup> for detection of the S genetic variant; the 144 bp PCR product from the SERPINA1 gene was digested with <i>Taq</i> I<sup>α</sup> enzyme for detection of the Z genetic variant. Mw1 is the molecular marker pBs+<i>Msp</i> I, Mw2 is the molecular marker λ+<i>Pst</i> I. P<sub>MBL</sub>, P<sub>IL8</sub>, P<sub>TNF</sub>, P<sub>AATS</sub> and P<sub>AATZ</sub> are undigested PCR products. The Z allele was not detected.</p

    Modifier gene genotype frequencies (%) in CF patients and control subjects; OR, Hardy–Weinberg Equilibrium (HWE) and results of the association test with Dominant Model <i>P</i>-values.

    No full text
    <p>CF, cystic fibrosis; OR, Odds Ratio; CI, confidence interval.</p>a<p>TNF1 −308 G: (dd) vs. (DD, Dd),</p>b<p>TNF2 −308 A: (DD, Dd) vs. (dd).</p><p>HW-P: <i>P</i>-value for the Hardy-Weinberg equilibrium.</p><p>X<sup>2</sup> Bonf. P = Chi squared test with a Bonferroni-corrected <i>P</i>-value.</p
    corecore